Advertisement

Topics

The Pfizer Foundation Company Profile

13:46 EDT 23rd September 2018 | BioPortfolio

The Pfizer Foundation is a charitable organization established by Pfizer Inc. The Foundation is a separate and independent tax-exempt organization. The Foundation’s mission is to promote access to quality health care, to nurture innovation, and to support the community involvement of Pfizer people.


News Articles [1513 Associated News Articles listed on BioPortfolio]

Pfizer Agrees To Pay $23.85M To Resolve Kickback Allegations

NewsAs part of the settlement, the government alleged that Pfizer used a foundation as a conduit to pay copay obligations of Medicare patients taking three Pfizer drugs: Sutent, Inlyta, and Tikosyn.

Pfizer To Pay $23.85 Mln To Resolve Kickback Claims: DoJ

NEW YORK CITY (dpa-AFX) - Drug giant Pfizer Inc. (PFE) has agreed to pay $23.85 million to settle allegations that that it used a foundation as a conduit to pay the copays of Medicare patients tak...

Pfizer Foundation Continues Support of Local Organizations through 2018 Global Health Innovation Grants

SOURCE: Pfizer DESCRIPTION:At Pfizer, we believe that all individuals deserve access to quality healthcare and the opportunity to lead healthy lives. As part of its efforts to support sustainable solu...

Pfizer Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at the ...

Pfizer Inc.Media:Neha Wadhwa212-733-2835Neha.Wadhwa@pfizer.comorDervila Keane+353 86 2110834Dervila.M.Keane@pfizer.comorInvestors:Bryan Dunn212-733-8917Bryan.Dunn@pfizer.com Read mo...

Pfizer's Q1 net jumps 14 pct., sales just miss expectations

This Dec. 4, 2017, file photo shows a tablet of Pfizer's Viagra, left, and the company's generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. Pfizer Inc. reports earn...

Pfizer to Pay $23.85 Million to Resolve Anti-Kickback Allegations

Pharmaceutical company Pfizer Inc. will pay $23.85 million to settle False Claims Act allegations that it induced Medicare patients to purchase its drugs via a “charitable foundation” that...

Pfizer To Expand Venture Investing With $600 Mln Commitment To Pfizer Venture

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said Wednesday that it plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures, the company's venture ...

Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne ...

Pfizer Inc.Media Relations:Neha Wadhwa, (212)733-2835Neha.Wadhwa@pfizer.comorInvestor:Chuck Triano, (212)733-3901Charles.E.Triano@pfizer.com Read more...

Drugs and Medications [546 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [226 Associated PubMed Articles listed on BioPortfolio]

The Florence Nightingale Foundation: developing nursing's leaders.

Ursula Ward, Chief Executive, Florence Nightingale Foundation, chiefexec@florence-nightingale-foundation.org.uk , describes the role of the foundation and its plans for the future.

Conserved cysteines in Mason-Pfizer monkey virus capsid protein are essential for infectious mature particle formation.

Retrovirus assembly is driven mostly by Gag polyprotein oligomerization, which is mediated by inter and intra protein-protein interactions among its capsid (CA) domains. Mason-Pfizer monkey virus (M-P...

Comments on Feskanich et al.: Milk and other dairy foods and risk of hip fracture in men and women.

Association between gout and osteoporosis risk in the United Kingdom.

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

Clinical Trials [341 Associated Clinical Trials listed on BioPortfolio]

Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

This extension study will evaluate the safety (including immunogenicity) of treatment with rituximab-Pfizer, as well as the safety and immunogenicity after transitioning from rituximab-US ...

A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

The primary objective of the study is to determine bioequivalence of 50 mg (2x25 mg) Artesunate Sachet (Pfizer) versus 50 mg (1x50 mg) tablet, Arsuamoon® (Guilin China) which is the World...

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))

This is a Phase 1, double blind (sponsor open), randomized (1:1:1), parallel group, 3 arm, single dose comparative PK study of adalimumab Pfizer and adalimumab sourced from the US and EU a...

A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects

The study will determine if amodiaquine tablet (Pfizer), an antimalaria agent, is pharmaceutically equivalent to a comparator product (Arsuamoon-Guilin China).

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

An open label, randomized, single-center, single-dose, two-treatment, two-period, crossover bioavailability study comparing Cetirizine Hydrochloride 10 mg tablet of Ohm Laboratories Inc. ...

Companies [1483 Associated Companies listed on BioPortfolio]

The Pfizer Foundation

The Pfizer Foundation is a charitable organization established by Pfizer Inc. The Foundation is a separate and independent tax-exempt organization. The Foundation’s mission i...

Renata Limited

Historical High-Lights: Founded in 1972 as a subsidiary of Pfizer Inc. Ownership transferred from Pfizer Inc. to local institutions and the general public in 1993. Company name subsequently changed fr...

Pfizer Ophthalmics

Pfizer Ophthalmics, a division of Pfizer Inc, is committed to preserving sight and eliminating preventable blindness. Pfizer Ophthalmics discovers, develops and provides leading treatments in ophthalm...

Bristol-Myers Squibb Company & Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-M...

Pfizer Consumer Healthcare

Centrum Silver

More Information about "The Pfizer Foundation" on BioPortfolio

We have published hundreds of The Pfizer Foundation news stories on BioPortfolio along with dozens of The Pfizer Foundation Clinical Trials and PubMed Articles about The Pfizer Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Pfizer Foundation Companies in our database. You can also find out about relevant The Pfizer Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record